175 related articles for article (PubMed ID: 5038775)
21. [Current views on the therapy of hepatic coma].
Ziegler K
Z Gesamte Inn Med; 1970 Apr; 25(8):341-3. PubMed ID: 4331690
[No Abstract] [Full Text] [Related]
22. [Therapeutic effect of a preparation of total liver extract, cyanocobalamin and amino acids of the Krebs cycle, in acute and chronic liver diseases].
Pignattari S; Sarti F; Toscano S; Dal Monte PR
Minerva Med; 1972 Jul; 63(53):2861-72. PubMed ID: 5049878
[No Abstract] [Full Text] [Related]
23. Effect of pyrrolidone carboxylate (PCA) and pyridoxine on liver metabolism during chronic ethanol intake in rats.
Calabrese V; Ragusa N; Rizza V
Int J Tissue React; 1995; 17(1):15-20. PubMed ID: 7499060
[TBL] [Abstract][Full Text] [Related]
24. [Liver, protein metabolism and branched-chain amino acids].
Bernardi R
Clin Ter; 1981 Dec; 99(6):653-75. PubMed ID: 7037278
[No Abstract] [Full Text] [Related]
25. [Possibility of the correction of hyperammoniemia during parenteral nutrition with amino acids].
Vetrò A; Mangiagalli M; Croce A
Minerva Dietol Gastroenterol; 1978; 24(4):339-42. PubMed ID: 118408
[No Abstract] [Full Text] [Related]
26. [Action of arginine in a recurrent hepatic coma complicating a feminizing tumor of the adrenal cortex with hepatic metastases].
Imler M; Ruscher H; Peter B; Kurtz D; Stahl J
Sem Hop; 1973 Nov; 49(48):3183-90. PubMed ID: 4364910
[No Abstract] [Full Text] [Related]
27. [Evaluation of peripheral and CNS biochemical changes in models of acute and chronic experimental hepatic insufficiency in the rat].
Rosati R; Montorsi M; Beccaria G; Santambrogio R; Salerno F; Malesci A; Abbiati R; Bonato C; Spina GP
Minerva Chir; 1983 Oct; 38(19):1489-92. PubMed ID: 6320059
[No Abstract] [Full Text] [Related]
28. [The use of a new drug association in the treatment of hyperazotemia. (Clinical study of a group of surgical patients)].
Petrucci P; Montagnani I
Omnia Med Ther; 1967; 45(4):849-56. PubMed ID: 5605419
[No Abstract] [Full Text] [Related]
29. Triple therapy with pyridoxine, arginine supplementation and dietary lysine restriction in pyridoxine-dependent epilepsy: Neurodevelopmental outcome.
Coughlin CR; van Karnebeek CD; Al-Hertani W; Shuen AY; Jaggumantri S; Jack RM; Gaughan S; Burns C; Mirsky DM; Gallagher RC; Van Hove JL
Mol Genet Metab; 2015; 116(1-2):35-43. PubMed ID: 26026794
[TBL] [Abstract][Full Text] [Related]
30. Reye's syndrome: ammonia intoxication as a possible factor in the encephalopathy.
Huttenlocher PR; Schwartz AD; Klatskin G
Pediatrics; 1969 Mar; 43(3):443-54. PubMed ID: 5812402
[No Abstract] [Full Text] [Related]
31. Hepatic encephalopathy in surgical patients.
Macpherson AI
J R Coll Surg Edinb; 1972 May; 17(3):161-6. PubMed ID: 5072919
[No Abstract] [Full Text] [Related]
32. Hepatic encephalopathy.
Hess RJ
Southwest Med; 1969 Oct; 50(10):174-6. PubMed ID: 5386877
[No Abstract] [Full Text] [Related]
33. [Importance of ammonia in the pathogensis of a hepatic comma].
Díaz Rubio M; Candel Monserrate I; Portugal Alvarez J
Rev Clin Esp; 1968 Mar; 108(5):356-62. PubMed ID: 5674474
[No Abstract] [Full Text] [Related]
34. [Research on the value of a taurine, nucleotide and vitamin combination in neurologic diseases].
Brogi L; Avesani A
Clin Ter; 1974 Aug; 70(4):357-78. PubMed ID: 4426172
[No Abstract] [Full Text] [Related]
35. [Parenteral feeding of patients with liver cirrhosis with hepatic encephalopathy].
Ferenci P; Wewalka F
Infusionsther Klin Ernahr; 1980 Apr; 7(2):72-8. PubMed ID: 6776052
[TBL] [Abstract][Full Text] [Related]
36. [Hepatic encephalopathy--therapy].
Wettstein M; Häussinger D
Dtsch Med Wochenschr; 2003 Dec; 128(50):2658-60. PubMed ID: 14673743
[No Abstract] [Full Text] [Related]
37. Ammonia toxicity under hyponatremic conditions in astrocytes: de novo synthesis of amino acids for the osmoregulatory response.
Zwingmann C; Leibfritz D
Neurochem Int; 2005 Jul; 47(1-2):39-50. PubMed ID: 15908044
[TBL] [Abstract][Full Text] [Related]
38. [Hepatic encephalopathy].
Demedts M; Fevery J; van de Woestijne K; de Pillen E Groote J
Tijdschr Gastroenterol; 1971; 14(3):161-72. PubMed ID: 5160353
[No Abstract] [Full Text] [Related]
39. [Nucleodoxin in the treatment of alcoholic myocardiopathies. Hemodynamic evaluations with the polygraphic method].
Forattini C
Omnia Med Ther; 1970; 48(3):361-73. PubMed ID: 5513564
[No Abstract] [Full Text] [Related]
40. [Therapeutic activity, evaluated by hepatoparenchymal clearence with indocyanine green, of a "taurine-nucleotide-vitamin" drug association in hepatic steatosis].
Proto C; Grasso G; Levi GF
Omnia Med Ther; 1967; 45(4):857-63. PubMed ID: 5605420
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
